The missing piece of the Microsoft Desktop Optimization Pack, Med-V, was released to manufacturing and is now available...
By submitting your email address, you agree to receive emails regarding relevant topic offers from TechTarget and its partners. You can withdraw your consent at any time. Contact TechTarget at 275 Grove Street, Newton, MA.
for production deployments on Windows 7.
Microsoft Enterprise Desktop Virtualization (Med-V) is the component of the MDOP available to Software Assurance customers that lets IT run applications that aren't supported or tested on Windows 7 in a virtual Windows XP environment.
The tool helps IT managers rectify a situation where legacy apps are incompatible with newer versions of Windows. But because it eliminates the need for application testing, IT managers can more quickly install newer versions of Windows.
"Customers can use MED-V to deliver applications in a virtual PC that runs a previous version of the OS, or they can move to Windows 7 while retaining the ability to run Windows 2000, Windows XP and Vista applications," said Donald Retallack, a systems security and management analyst at Kirkland, Wash.-based Directions on Microsoft, an independent analysts firm.
MED-V also reduces management workloads and costs because VMs are centrally created, deployed and updated, and a master image can be used for many PCs, Retallack said.
To get MED-V1.0 SP1, which supports Windows 7 hosts including 32-bit and 64-bit, Windows Server 2008 R2 and Windows XP SP3, customers can download MDOP 2010 Refresh at the Volume Licensing Service Center.
MDOP is only available to Software Assurance (SA) customers. It includes Asset Inventory Service (AIS), Application Virtualization (App-V), Advanced Group Policy Management (AGPM), Diagnostic and Recovery Toolset (DaRT) and Desktop Error Monitoring (DEM).
MDOP 2009 for Windows 7 was released in October 2009 and MDOP 2010 launched in February.
Microsoft also updated App-V 4.6 with localized versions of the App-V client for 23 languages.
Let us know what you think about the story; email Bridget Botelho, News Writer or follow @BridgetBotelho on Twitter